Absci Corp. (ABSI)
8.805
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 15:23
Absci Cash from Investing (Quarterly) : 24.07M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.07M |
| March 31, 2026 | 7.362M |
| December 31, 2025 | 19.55M |
| September 30, 2025 | -63.70M |
| June 30, 2025 | 9.039M |
| March 31, 2025 | -15.04M |
| December 31, 2024 | 19.04M |
| September 30, 2024 | 14.81M |
| June 30, 2024 | 1.255M |
| March 31, 2024 | -76.68M |
| December 31, 2023 | 18.96M |
| September 30, 2023 | 20.14M |
| June 30, 2023 | 70.15M |
| Date | Value |
|---|---|
| March 31, 2023 | -27.30M |
| December 31, 2022 | -30.18M |
| September 30, 2022 | -78.72M |
| June 30, 2022 | -11.22M |
| March 31, 2022 | -6.857M |
| December 31, 2021 | -8.316M |
| September 30, 2021 | -6.82M |
| June 30, 2021 | -43.36M |
| March 31, 2021 | -8.876M |
| December 31, 2020 | -0.91M |
| September 30, 2020 | -0.735M |
| June 30, 2020 | -0.337M |
| March 31, 2020 | -0.189M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Twist Bioscience Corp. | -10.20M |
| Prime Medicine, Inc. | 24.03M |
| Beam Therapeutics, Inc. | -9.875M |
| Tenax Therapeutics, Inc. | 0.00 |
| Manhattan Scientifics, Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.56M |
| Cash from Financing (Quarterly) | 102.73M |
| Free Cash Flow | -108.97M |
| Free Cash Flow Per Share (Quarterly) | -0.175 |
| Free Cash Flow to Equity (Quarterly) | -26.98M |
| Free Cash Flow to Firm (Quarterly) | -27.56M |
| Free Cash Flow Yield | -8.19% |